An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are urged to contact these accounts privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.
Several professionals said the popularity for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Material Removal
Based on the social media company, the service has taken down problematic material and banned associated hashtags and search suggestions. The company said it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Investigations also found groups with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, positive reviews and detailed instructions for preparing or administering at residence.
After moments of entering one group, a seller posted contact information, where most purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Product Details and Costs
Within these communities, posts show dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service stated it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the research behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are using social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has previously encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly significant medical dangers”.
